MHP
ETRM

Manatuck Hill Partners’s EnteroMedics Inc. ETRM Stock Holding History

Manatuck Hill Partners’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-190
Closed -$249K – 128
2013
Q3 		$249K Buy
+190
New +$221K 0.03% 86

Other funds holding ETRM

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Manatuck Hill Partners's ETRM Position: Q4 2013 in Review

Manatuck Hill Partners sold out of EnteroMedics Inc. (ETRM) in Q4 2013, closing a stake of 190 shares — an estimated $249K sold.

Manatuck Hill Partners first reported a position in ETRM in Q3 2013 and held it in 1 quarter. The position peaked at $249K in Q3 2013. 50 funds tracked by Wall St. Rank hold ETRM as of Q4 2013.

  • Manatuck Hill Partners reported no remaining EnteroMedics Inc. position as of Q4 2013 after selling out during the quarter.
  • Manatuck Hill Partners sold 190 EnteroMedics Inc. shares in Q4 2013, an estimated $249K.
  • Manatuck Hill Partners first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 1 quarter.
  • Manatuck Hill Partners's EnteroMedics Inc. position peaked at $249K in Q3 2013.
  • 50 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2013.

Based on Manatuck Hill Partners's 13F filing for Q4 2013, filed 14 Feb 2014.